SMED Strudwick type (SEMDSTWK) SEMD Shohat type (SEMDSH) SEMD Faden-Alkuraya type (SEMDFA) SEMD Di Rocco type (SEMDDR) SEMD Isidor-Toutain type (SEMDIST) SEMD Krakow type (SEMDK) SEMD Aggrecan type (SEMDAG) SEMD Genevieve type (SEMDG) SEMD Sponastrime type (SEMSP) X-linked SEMD (SEMDX) SEMD Pakistani type [DS:H00761] SEMD Matrilin type [DS:H00767] SEMD Short limb-hand type [DS:H00777] SEMD with joint laxity type [DS:H01494] SEMD Missouri type (SEMDM) SEMD X-linked, with hypomyelinating leukodystrophy (SEMDHL) SEMD Guo-Campeau type (SEMDGC)
Description
Spondyloepimetaphyseal dysplasia (SEMD) is a heterogeneous group of skeletal dysplasias (dwarfing disorders) characterized by abnormal epiphyses, with varying degrees of metaphyseal irregularities, flattened vertebral bodies, and myopia.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
20 Developmental anomalies
Multiple developmental anomalies or syndromes
LD24 Syndromes with skeletal anomalies as a major feature
H02187 Spondyloepimetaphyseal dysplasia
Pathway-based classification of diseases [BR:br08402]
Cellular process
nt06539 Cytoskeleton in muscle cells
H02187 Spondyloepimetaphyseal dysplasia
Egunsola AT, Bae Y, Jiang MM, Liu DS, Chen-Evenson Y, Bertin T, Chen S, Lu JT, Nevarez L, Magal N, Raas-Rothschild A, Swindell EC, Cohn DH, Gibbs RA, Campeau PM, Shohat M, Lee BH
Title
Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia.
Faden M, AlZahrani F, Mendoza-Londono R, Dupuis L, Hartley T, Kannu P, Raiman JA, Howard A, Qin W, Tetreault M, Xi JQ, Al-Thamer I, Maas RL, Boycott K, Alkuraya FS
Title
Identification of a Recognizable Progressive Skeletal Dysplasia Caused by RSPRY1 Mutations.
Le Caignec C, Ory B, Lamoureux F, O'Donohue MF, Orgebin E, Lindenbaum P, Teletchea S, Saby M, Hurst A, Nelson K, Gilbert SR, Wilnai Y, Zeitlin L, Segev E, Tesfaye R, Nizon M, Cogne B, Bezieau S, Geoffroy L, Hamel A, Mayrargue E, de Courtivron B, Decock-Giraudaud A, Charrier C, Pichon O, Retiere C, Redon R, Pepler A, McWalter K, Da Costa L, Toutain A, Gleizes PE, Baud'huin M, Isidor B
Title
RPL13 Variants Cause Spondyloepimetaphyseal Dysplasia with Severe Short Stature.
Cho SY, Bae JS, Kim NKD, Forzano F, Girisha KM, Baldo C, Faravelli F, Cho TJ, Kim D, Lee KY, Ikegawa S, Shim JS, Ko AR, Miyake N, Nishimura G, Superti-Furga A, Spranger J, Kim OH, Park WY, Jin DK
Title
BGN Mutations in X-Linked Spondyloepimetaphyseal Dysplasia.
Mierzewska H, Rydzanicz M, Bieganski T, Kosinska J, Mierzewska-Schmidt M, Lugowska A, Pollak A, Stawinski P, Walczak A, Kedra A, Obersztyn E, Szczepanik E, Ploski R
Title
Spondyloepimetaphyseal dysplasia with neurodegeneration associated with AIFM1 mutation - a novel phenotype of the mitochondrial disease.
Guo L, Salian S, Xue JY, Rath N, Rousseau J, Kim H, Ehresmann S, Moosa S, Nakagawa N, Kuroda H, Clayton-Smith J, Wang J, Wang Z, Banka S, Jackson A, Zhang YM, Wei ZJ, Huning I, Brunet T, Ohashi H, Thomas MF, Bupp C, Miyake N, Matsumoto N, Mendoza-Londono R, Costain G, Hahn G, Di Donato N, Yigit G, Yamada T, Nishimura G, Ansel KM, Wollnik B, Hrabe de Angelis M, Megarbane A, Rosenfeld JA, Heissmeyer V, Ikegawa S, Campeau PM
Title
Null and missense mutations of ERI1 cause a recessive phenotypic dichotomy in humans.
Familial thoracic aortic aneurysm and dissection [DS:H00801]
Description
Meester-Loeys syndrome (MRLS) is an X-linked thoracic aortic aneurysm and dissection (TAAD) syndrome. In addition to the aorta, aneurysms in the brain, pulmonary artery, and ductus arteriosus have been described. The disease is caused by loss-of-function mutations in the biglycan gene (BGN). Biglycan is a small leucine-rich class I proteoglycan involved in the maintenance and assembly of the extracellular matrix (ECM).
Category
Cardiovascular disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
20 Developmental anomalies
Multiple developmental anomalies or syndromes
LD28 Syndromes with connective tissue involvement as a major feature
H02720 Meester-Loeys syndrome
Pathway-based classification of diseases [BR:br08402]
Cellular process
nt06539 Cytoskeleton in muscle cells
H02720 Meester-Loeys syndrome
Meester JAN, Hebert A, Bastiaansen M, Rabaut L, Bastianen J, Boeckx N, Ashcroft K, Atwal PS, Benichou A, Billon C, Blankensteijn JD, Brennan P, Bucks SA, Campbell IM, Conrad S, Curtis SL, Dasouki M, Dent CL, Eden J, Goel H, Hartill V, Houweling AC, Isidor B, Jackson N, Koopman P, Korpioja A, Kraatari-Tiri M, Kuulavainen L, Lee K, Low KJ, Lu AC, McManus ML, Oakley SP, Oliver J, Organ NM, Overwater E, Revencu N, Trainer AH, Trivedi B, Turner CLS, Whittington R, Zankl A, Zentner D, Van Laer L, Verstraeten A, Loeys BL
Title
Expanding the clinical spectrum of biglycan-related Meester-Loeys syndrome.